<DOC>
	<DOCNO>NCT01457846</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety tolerability AZD4547 compare paclitaxel patient advance gastric lower-oesophageal cancer whose tumour find FGFR2 polysomy gene amplification .</brief_summary>
	<brief_title>Efficacy Safety AZD4547 Versus Paclitaxel Patients With Advanced Gastric Gastro-oesophageal Cancer</brief_title>
	<detailed_description>A Randomised Open-Label Phase IIa Study Assess Efficacy Safety AZD4547 monotherapy versus paclitaxel Patients Advanced Gastric Gastro-oesophageal Junction Cancer FGFR2 Polysomy Gene Amplification ( SHINE study ) . Patients assign strata FGFR2 status : polysomy , low high gene amplification .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Female male age 25 Histological diagnosis locally advance metastatic gastro adenocarcinoma ( include adenocarcinoma low third oesophagus gastro oesophageal junction ) Radiographically confirm progression 1 prior chemotherapy chemoradiotherapy gastric cancer . Suitable expected benefit paclitaxel monotherapy . At least one lesion , previously irradiate , baseline least 10mm long diameter non nodal lesion assess Computerised Tomography ( CT ) Magnetic Resonance Imaging ( MRI ) Provision either archival tumour sample fresh tumour sample confirmation FGFR2 polysomy/gene amplification Prior exposure AZD4547 history hypersensitivity drug similar structure class AZD4547 . Hypersensitivity paclitaxel formulate cremophor EL ( polyoxyethylated castor oil ) Prior taxane treatment gastric cancer exception adjuvant/neoadjuvant therapy give &gt; 6 month ; Major surgery , radiotherapy wide field radiation cancer treatment within 4 week first dose study treatment With exception alopecia , unresolved toxicity prior therapy Common Terminology Criteria AE ( CTCAE ) grade &gt; 1 time start study treatment . Blood Echocardiogram ( ECG ) reading deem abnormal fall outside reference range protocol inclusion/exclusion section . Taking regular medication predict interact AZD4547 due route metabolism .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>gastro-oesophageal junction cancer</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>low third oesophageal cancer</keyword>
	<keyword>polysomy</keyword>
	<keyword>amplification</keyword>
	<keyword>FGFR</keyword>
</DOC>